NEPHROPLUS
NSENephrocare Health Services Limited (SMALL CAP)
Healthcare>Healthcare>Healthcare Services>Healthcare Service Provider
₹748.15
3.15 (0.42%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹7.51K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Healthcare Service Provider
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹446+67.7%
52W High₹769.75-2.8%
Current Price
₹748.15
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹598.52
Upper Circuit₹897.78
Reference Price
₹748.15
Investment Checklist
Head and Shoulders on 1D — target ₹455.7
Triple Top on 1D — target ₹455.7
Trend: Price above all key MAs — strong uptrend
Volume divergence: Bearish (price up, volume down)
RSI at 76.5 — overbought, pullback risk
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
47%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
660.08
EMA50
610.22
Price Action
UPTREND
BULLISH
Higher Highs8
Higher Lows8
Lower Highs1
Lower Lows1
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹663.90
₹616.00
₹598.92
₹541.95
₹519.25
Volume Analysis
TrendDECREASING
Change-25.60%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹740.67
3% Risk₹725.71
5% Risk₹710.74
7% Risk (Custom)
₹695.78Technical Levels
1x ATR (Volatility)₹713.87
2x ATR (Swing)₹679.59
3x ATR (Trend)₹645.31
Immediate Support₹663.90
Moving Averages
EMA 9 (Short-term)₹700.33
EMA 20 (Medium-term)₹660.08
EMA 50 (Trend)₹610.22
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Dec '25 |
|---|---|---|---|
| Revenue | ₹197.3 Cr | ₹211.7 Cr | ₹259.7 Cr |
| Net Profit | ₹20.1 Cr | ₹24.9 Cr | ₹32.2 Cr |
| EPS | ₹2.00 | — | ₹3.43 |
| Operating Profit | ₹49.5 Cr | ₹53.4 Cr | ₹64.2 Cr |
ROE
11.49%
ROCE
12.63%
Debt/Equity
0.44
Current Ratio
1.92
OPM
24.71%
NPM
12.41%
Peer Comparison
Healthcare Service ProviderPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| LALPATHLAB | Dr. Lal Path Labs Ltd. | ₹1,601.50 | +0.50% |
| VIJAYA | Vijaya Diagnostic Centre Limited | ₹1,287.20 | +0.63% |
| THYROCARE | Thyrocare Technologies Limited | ₹528.90 | +1.83% |
| METROPOLIS | Metropolis Healthcare Limited | ₹530.70 | +2.03% |
| KRSNAA | Krsnaa Diagnostics Limited | ₹534.30 | +0.23% |
| SURAKSHA | Suraksha Diagnostic Limited | ₹268.05 | +0.00% |
| 3BBLACKBIO | 3B Blackbio Dx Limited | ₹1,245.40 | -0.69% |
| HEALTHX | Health X Platform Limited | ₹280.90 | +0.90% |
| CHANDAN | Chandan Healthcare Limited | ₹226.80 | +1.18% |
| INVICTA | Invicta Diagnostic Limited | ₹59.95 | -1.72% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for NEPHROPLUS
View AllNEWS
positive
Business Standard - Markets 3d ago
NEPHROPLUS to acquire dialysis center assets in Paranaque City, Philippines
NEPHROPLUSHealthcare
NEWS
positive
Business Standard - Markets 8d ago
Nephrocare Health Services gains as arm acquires dialysis centre assets in Philippines
Nephrocare Health Services rose 1.32% to Rs 670 after its wholly owned subsidiary, Nephrocare Health Care Services Philippines Inc., has entered into an Asset Transfer Agreement with Inocentes Dialysis Clinic.
AGARWALEYEAMRUTANJANMEDANTANEPHROCARENEPHROPLUSPGHHZOTAFast Moving Consumer GoodsHealthcare
positive
LiveMint - Markets 89d ago
Fractal Analytics, Park Medi, two others slip up to 7% as lock-in for 3.6 crore shares expires today
Following the end of IPO lock-in periods on March 16, Fractal Analytics, Aye Finance, Park Medi World, and Nephrocare Health Services faced share price drops. This release of 3.6 crore shares marks the beginning of a potential $72 billion unlock for 88 companies through 2026.
AYEFRACTALLTFMEDANTANEPHROCARENEPHROPLUSPARKHOSPSPROPEQUITYFinancial ServicesHealthcare